The CRUK Facilitator programme: from the lab to the clinic
Safety Profile of CAR-T Cell JCAR017 in R/R Aggressive B-NHL patients
Making the market more competitive - the potential benefit of biosimilars
Are biosimilars similar enough?
Clinical evidence supporting rituximab
Won Seog Kim